Atlas Trials

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Clinical trial NCT00867321 · COMPLETED

Trial details

NCT number
NCT00867321
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2009-04-01
Primary completion
2012-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.